GlobalRPh RX List - FARESTON
- Product / population
- Oral toremifene; renal pharmacokinetic statement, not an all-population regimen.
- Renal measure
- Renal impairment described qualitatively in the selected section.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
The source reports similar pharmacokinetics in subjects with and without renal impairment. No numeric renal bands or dialysis schedule are supplied in the selected paragraph. Preserve this as a limited pharmacokinetic observation rather than an independently established no-adjustment protocol.